.

Idera Pharmaceuticals reported $26.31M in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agenus AGEN:US $ 456.17M 14.87M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Amgen AMGN:US $ 59294M 98M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Cytrx CYTR:US 6.56M 2.16M
Dynavax Technologies DVAX:US $ 1023M 14.02M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 8904500M 64400M
Idera Pharmaceuticals IDRA:US $ 26.31M 3.83M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M